Jonathan Milner

 Jonathan Milner
Jonathan Milner
Meltwind
Speaker

Presentations at Drug Discovery 2018

Wed10  Oct09:10am(45 mins)
Opportunities in the Golden Age of Biology

Session: Plenary Keynote - Day 2
Room: Platinum Suite 1

Profile of Jonathan Milner

Jonathan, co-Founder and currently Deputy Chairman of Abcam plc, is an entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 40 companies and has assisted three technology companies to IPO on the London AIM Stock exchange.
Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath. From 1992–95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the lab of Professor Tony Kouzarides researching the molecular basis of breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies, and in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides.
Jonathan is also Chairman of Axol Bioscience, Cambridge Allergy Therapy, and PhoreMost; and a non-executive director of Horizon Discovery, Repositive, HealX and Syndicate Room.
In 2015 Jonathan, with Professor Tony Kouzarides, co-founded the Milner Therapeutics Institute at the University of Cambridge. Also in 2015 he co-founded, with Professor Laurence Hurst, the Milner Institute for Evolution at the University of Bath.

Email
Please login to send a Private Message

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
www.myeventflo.com/2109
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018